Linked Life Data

20172361

Source:http://linkedlifedata.com/resource/pubmed/id/20172361

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2010-2-22
pubmed:abstractText
Cancer staging has been the lynchpin of diagnosis, treatment, and prognosis for several years. However, new advances in molecular genetics, statistics, and computer science have been mounting a challenge to cancer staging in accurate prognostication. Staging systems, such as tumor-node-metastasis (TNM) classification, have been reacting to these challenges by increasing the number of stage groupings. In this article we examine the history of the number of increases in stage groups and argue that recent increases have not been accompanied by increased ease of use or better prognostic ability. We recommend that parsimony should be considered to counterbalance the instinct to increase the number of categories in future revisions of staging systems such as TNM.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1532-8708
pubmed:author
pubmed:copyrightInfo
Copyright 2010 Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
37
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
27-30
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Whither TNM?
pubmed:affiliation
Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. gonenm@mskcc.org
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't